provera
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.92 | $55.02 (0%) | 🛒 Add to cart |
| 90 | $0.84 | $82.53 $76.02 (8%) | 🛒 Add to cart |
| 120 | $0.81 | $110.04 $97.03 (12%) | 🛒 Add to cart |
| 180 | $0.77 | $165.05 $139.05 (16%) | 🛒 Add to cart |
| 270 | $0.75 | $247.58 $202.07 (18%) | 🛒 Add to cart |
| 360 | $0.74
Best per pill | $330.11 $265.09 (20%) | 🛒 Add to cart |
Synonyms
| |||
Provera is the brand name for medroxyprogesterone acetate, a synthetic progestin that’s been a workhorse in women’s health since the 1960s. What’s fascinating about this compound isn’t just its chemical structure—it’s how this molecule has shaped modern gynecological practice across multiple generations of patients. I remember my first rotation in gynecology back in ‘98, watching Dr. Henderson pull out his prescription pad for what seemed like every third patient. “Provera,” he’d say, “the Swiss Army knife of hormones.” At the time, I didn’t fully appreciate just how versatile this medication would become in my own practice.
Provera: Hormone Regulation for Menstrual Disorders and Endometrial Protection - Evidence-Based Review
1. Introduction: What is Provera? Its Role in Modern Medicine
Provera contains medroxyprogesterone acetate as its active pharmaceutical ingredient—a synthetic derivative of progesterone that’s structurally similar to the natural hormone but with enhanced oral bioavailability and prolonged duration of action. Unlike natural progesterone, which undergoes extensive first-pass metabolism, this compound maintains therapeutic blood levels for extended periods, making it particularly useful for conditions requiring sustained progestogenic effects.
What is Provera used for in clinical practice? Well, it’s primarily indicated for treating secondary amenorrhea, abnormal uterine bleeding due to hormonal imbalance, and as part of hormone replacement therapy to protect the endometrium in women with intact uteri receiving estrogen. The benefits of Provera extend beyond just regulating menstrual cycles—it’s fundamentally about restoring hormonal balance and preventing pathological changes in endometrial tissue.
2. Key Components and Bioavailability Provera
The composition of Provera is deceptively simple—medroxyprogesterone acetate is the sole active component, typically formulated in 2.5mg, 5mg, and 10mg tablets. What many clinicians don’t realize is that the crystalline structure and particle size distribution in the manufacturing process significantly affect dissolution rates and, consequently, clinical effects.
Bioavailability of Provera is nearly complete after oral administration, with peak plasma concentrations occurring within 2-4 hours. The compound undergoes hepatic metabolism primarily via CYP3A4, with an elimination half-life of approximately 24-30 hours—significantly longer than natural progesterone’s 5-20 minute half-life. This extended duration means we can achieve therapeutic effects with once-daily dosing in most cases, though I’ve found some patients do better with divided doses for certain indications.
3. Mechanism of Action Provera: Scientific Substantiation
How Provera works at the molecular level is both elegant and complex. The mechanism of action involves binding to intracellular progesterone receptors in target tissues, particularly the endometrium. Once bound, the receptor-ligand complex translocates to the cell nucleus where it modulates gene transcription—essentially telling endometrial cells to stop proliferating and begin secretory differentiation.
The effects on the body extend beyond the endometrium though. Scientific research has demonstrated that medroxyprogesterone acetate suppresses gonadotropin secretion from the pituitary gland, which explains its utility in managing conditions like endometriosis where we want to create a pseudo-pregnancy state. It also competes for androgen receptors, which accounts for some of its androgenic side effects in certain patients.
4. Indications for Use: What is Provera Effective For?
Provera for Secondary Amenorrhea
For treatment of secondary amenorrhea, we typically use 5-10mg daily for 5-10 days. Withdrawal bleeding usually occurs within 3-7 days after discontinuation. The key here is establishing whether the endometrium has been primed with endogenous or exogenous estrogen—without adequate priming, you won’t get the desired withdrawal bleed.
Provera for Abnormal Uterine Bleeding
For abnormal uterine bleeding due to hormonal imbalance, the standard approach is 5-10mg daily for 5-10 days, though I often start with the lower dose and adjust based on response. The goal is to stabilize the endometrium and prevent erratic breakdown.
Provera for Endometrial Protection
In women receiving estrogen replacement therapy, we add Provera for prevention of endometrial hyperplasia—typically 2.5-10mg daily for 12-14 days per month in sequential therapy, or 2.5-5mg daily in continuous combined regimens.
5. Instructions for Use: Dosage and Course of Administration
Dosage varies significantly based on indication, and how to take Provera properly requires understanding the therapeutic goal:
| Indication | Dosage | Frequency | Duration | Administration |
|---|---|---|---|---|
| Secondary amenorrhea | 5-10mg | Once daily | 5-10 days | With or without food |
| Abnormal uterine bleeding | 5-10mg | Once daily | 5-10 days | Best with food to reduce nausea |
| Endometrial protection (sequential) | 5-10mg | Once daily | 12-14 days/month | Consistent timing |
| Endometrial protection (continuous) | 2.5-5mg | Once daily | Continuous | Same time daily |
The course of administration should be tailored to individual response. Side effects like bloating, breast tenderness, and mood changes often diminish after the first few cycles, but persistent symptoms may warrant dose adjustment.
6. Contraindications and Drug Interactions Provera
Contraindications for Provera include known hypersensitivity, active thrombophlebitis or thromboembolic disorders, undiagnosed vaginal bleeding, known or suspected pregnancy, and history of hormone-sensitive cancers. The safety during pregnancy category is X—absolutely contraindicated due to risk of fetal genital abnormalities.
Important drug interactions with Provera include reduced efficacy when co-administered with drugs that induce hepatic enzymes like carbamazepine, phenytoin, and rifampin. Conversely, Provera may alter the metabolism of cyclosporine and some anticonvulsants, requiring monitoring.
7. Clinical Studies and Evidence Base Provera
The scientific evidence supporting Provera use is extensive, dating back to the 1960s. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial demonstrated that adding medroxyprogesterone acetate to estrogen therapy effectively prevented endometrial hyperplasia—reducing incidence from 20-30% with estrogen alone to less than 1% with combination therapy.
More recent physician reviews have focused on optimal dosing strategies. A 2018 systematic review in Menopause journal concluded that continuous combined therapy with 2.5mg daily provides adequate endometrial protection with better bleeding control than sequential regimens for most women. The effectiveness in managing abnormal uterine bleeding was confirmed in multiple randomized trials, with success rates of 70-85% depending on the underlying etiology.
8. Comparing Provera with Similar Products and Choosing a Quality Product
When comparing Provera with similar progestins, the key differences lie in androgenic activity, metabolic effects, and patient-specific factors. Micronized progesterone (Prometrium) has less androgenic activity but more sedative effects. Norethindrone has more androgenic potential but may be better for bone protection. Which Provera alternative is better depends entirely on the individual patient’s risk profile and tolerance.
How to choose the right progestin involves considering the indication, route of administration, side effect profile, and cost. For pure endometrial protection without additional benefits, generic medroxyprogesterone acetate remains the most cost-effective option with decades of safety data.
9. Frequently Asked Questions (FAQ) about Provera
What is the recommended course of Provera to achieve results?
For most menstrual disorders, we start with 5-10mg daily for 5-10 days, with expected results within one treatment cycle. For endometrial protection, continuous daily dosing or cyclic administration for 12-14 days monthly provides ongoing protection.
Can Provera be combined with birth control pills?
Generally not recommended, as combined oral contraceptives already contain progestins. However, we sometimes use short courses to manage breakthrough bleeding while continuing the primary contraceptive method.
How long does it take for Provera to regulate periods?
Most women will experience withdrawal bleeding within 3-7 days after completing a 5-10 day course. Regular cycles may take 2-3 months to establish after cyclic therapy.
What are the most common side effects of Provera?
Weight gain, bloating, breast tenderness, mood changes, and headaches are most frequently reported. These often improve after the first few treatment cycles as the body adjusts.
10. Conclusion: Validity of Provera Use in Clinical Practice
The risk-benefit profile of Provera remains favorable for its approved indications, particularly given its extensive safety database spanning over five decades. While newer agents offer theoretical advantages for specific patient subsets, medroxyprogesterone acetate continues to provide reliable, cost-effective management for common gynecological conditions when used appropriately.
I had this patient, Sarah—42-year-old accountant with six months of erratic bleeding that was disrupting her life and frankly scaring her. Her OB/GYN had started her on Provera 10mg for 10 days, but she came to me for a second opinion because the bleeding pattern afterward concerned her. What struck me was how textbook her case was—anovulatory cycles with build-up of unstable endometrium—but her anxiety wasn’t in the textbooks.
We actually had some disagreement in our practice about whether to continue the same regimen or switch to continuous low-dose. My partner argued for switching, worried about the emotional rollercoaster she described. But looking at her endometrial thickness on ultrasound and knowing how the medication works, I felt we needed one more cycle to fully shed that built-up tissue.
What surprised me was how dramatically different her response was the second month—minimal side effects, predictable withdrawal bleed, and most importantly, resolution of her anxiety once she understood what was happening. She sent me a note last week, two years later, saying that brief course of treatment literally gave her her life back. Those are the cases that remind me why we still need these older, well-understood medications in our toolkit—they work predictably when you understand their nuances.
The failed insight for me was assuming all patients would respond similarly. We had another woman, Maria, same protocol, completely different experience—persistent bloating and mood effects that necessitated switching to micronized progesterone. That’s the art of this medicine—knowing when to stick with a treatment and when to pivot.
Looking back at my 20-plus years using this medication, what stands out isn’t the dramatic cases but the thousands of ordinary women whose lives became more manageable because we had this reliable option. The longitudinal follow-up on many of these patients shows that when used appropriately, it remains a cornerstone of gynecologic therapeutics.